ABVC BIOPHARMA, INC. (ABVC) › Operating IncomeABVC BIOPHARMA, INC. (ABVC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$1.89M2011: -$1.89M2012: -$1.14M2013: -$177.3K2016: -$11.00M2017: -$4.14M2018: -$2.78M2019: -$3.46M2020: -$8.51M2021: -$11.71M2022: -$15.11M2023: -$6.77M2024: -$4.71M2025: -$7.15M-$7.15M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$7.15M-52.0%2024-$4.71M+30.5%2023-$6.77M+55.2%2022-$15.11M-29.1%2021-$11.71M-37.6%2020-$8.51M-145.9%2019-$3.46M-24.2%2018-$2.78M+32.7%2017-$4.14M+62.4%2016-$11.00M—2013-$177.3K+84.5%2012-$1.14M+39.5%2011-$1.89M+0.1%2010-$1.89M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share